Table 1

Mutation screening of TBX1 in 105 patients

Position Nucleotide change1-150 Amino acid change No of patients1-151 No of controls1-151 Patient Diagnosis Parents
(A) Rare variants
Exon 239nt 5′ to ATG C→TNo1/1050/101p23DGSMother is carrier
Exon 5576 C→T192(Arg/Arg)1/1050/101p60TANot available
Exon 7886 C→A296(Arg/Arg)1/1051/101p59IAA typeBNot available
Exon 91049 G→A350(Gly/Asp)1/1050/101Ap22AAANot available
1187 C→T396(Pro/Leu)1/1050/100Ap18AAANot available
1274-1281delACTATCTCframeshift1/1050/139p13DGSMother is carrier
1334-1348del15bp1-152 445-449delGYHPH1/1050/139p23DGSFather is carrier
1371-1372insCAC457-458insHis1/1050/139p22VCFSMother is carrier
1399-1427dup30bp1-153 466-476dup10Ala1/1050/139p46IAANot available
1404-1412delCGCTGCCGC468-471del3Ala1/1050/1391-154 p65DGS/VCFSMother is carrier
(B) Common polymorphisms
Exon 275nt 5′to ATG G→CNo38/10535/101
Exon 3297 G→A99(Ala/Ala)11/1051/11
Exon 4420 T→C140(Phe/Phe)4/1052/24
Exon 5664 C→T222(Leu→Leu)37/1055/10
Intron 746nt to splice acceptorNo15/1051/10
Exon 8933 A→G311(Ala/Ala)37/1054/10
Exon 91059 A→G353(Ala/Ala)15/10511/101
1189 C→A397(His/Asn)37/10539/100
  • 1-150 nt1 refers to the first nucleotide of the initiation codon ATG.

  • 1-151 The numbers of patients or controls with polymorphisms or variants are reported for heterozygotes. Complete genotyping was not performed in this study.

  • 1-152 Deletion of GCTACCACCCGCACG.

  • 1-153 Duplication of GCCGCCGCTGCCGCAGCTGCCGCGGCCGCC.

  • 1-154 Two normal subjects were found, each with a different 9 bp deletion in the same region.